Treatment at low-scoring hospitals may increase risk for repeat heart attack and death

Heart attack patients treated at hospitals with low care scores are at greater risk for another heart attack and/or death due to cardiovascular causes, Rutgers researchers found.

Their study, published in the American Journal of Cardiology, compared care scores in the New Jersey Hospital Performance Reports with one-month and one-year rates of readmission for heart attack or death due to cardiovascular causes.

Researchers reviewed the electronic medical records of more than 160,000 patients at 80 New Jersey acute care hospitals from 2004 to 2015.

In low-scoring hospitals, 3 percent of heart attack patients returned to the hospital for a new heart attack within 30 days. At one year, 13 percent were readmitted and about 8 percent died from cardiovascular causes.

Patients who were admitted to a teaching hospital had a 25 percent lower chance of readmission at one month. At one year, the chance of these patients suffering cardiovascular death was 10 percent lower than patients initially admitted to a non-teaching hospital.

The study found a higher risk for a new heart attack and/or death among patients with conditions including acute heart failure, high blood pressure or chronic obstructive pulmonary disease. But those risks were reduced in patients who were treated at a teaching hospital.

"Hospital performance scores have real health implications for patients who have had a heart attack," said lead author William Kostis, an associate professor at Rutgers Robert Wood Johnson Medical School's Cardiovascular Institute. "We already knew that the scores affect patients' choices. When asked to prioritize hospital cost or hospital safety, patients prefer the safer hospital 97 percent of the time, regardless of cost."

Kostis noted that healthcare providers can reduce the risk of death or recurrence of heart attack by calling them after discharge to assess whether they are taking their medications as prescribed.

Source: https://www.rutgers.edu/

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Medicare coverage for obesity drug raises questions